Ok the new number is under $1. Noted. Let’s see if you guys can get us there. As for valuation, you are wrong, IMO. Here is why. We have two recent easy comps in which to properly value Titan. Memic and Vicarious are both single port offerings. Both valued at a billion dollars by the SPACs that they reverse merged into. Memic is a single port without a camera, has about 20 patents and may have significant patent issues with its snake like arms. Vicarious is years(4-5 years) from FDA approval has 5 patents and again may run into significant IP issues. Titan on the other hand is anticipating FDA approval in 2023, has almost 180 patents or patent pending. The patents that are the most important have freedom to operate and many of which are deemed desirable from the biggest player in the market other than Intuititve and you think they are a 200-300 million company? 1 and 1 does not equal 2 evidently.